| Diffuse Midline Glioma, H3 K27M-Mutant studied in …STUDIED_INderived28 of 28show fewer |
|---|
| → studied in | NCT05077735Phase 2 · active not recruiting Stereotactic Biopsy Split-Course Radiation Therapy in Diffuse Midline Glioma, SPORT-DMG Trial · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06357377Phase 1 · recruiting A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07389278Phase 1/Phase 2 · not yet recruiting Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG) · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05839379recruiting Targeted Pediatric High-Grade Glioma Therapy · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06860594Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma · condition mapped CURATED_BROADER · 28 trials mapped (20 active) | — | — | Adult Diffuse Midline Glioma, H3 K27-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06161974Phase 2 · recruiting Study of Olutasidenib and Temozolomide in HGG · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05476939Phase 3 · recruiting Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05544526Phase 1 · recruiting CAR T Cells to Target GD2 for DMG · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06624371Phase 1 · recruiting Atovaquone Combined With Radiation in Children With Malignant Brain Tumors · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05478837Phase 1 · terminated Genetically Modified Cells (KIND T Cells) for the Treatment of HLA-A*0201-Positive Patients With H3.3K27M-Mutated Glioma · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05835687Phase 1 · active not recruiting Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05009992Phase 2 · recruiting Combination Therapy for the Treatment of Diffuse Midline Gliomas · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06806228Phase 1 · suspended Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status) · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05843253Phase 2 · recruiting Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07589257Phase 2 · recruiting A Study of VRT106 in Combination With Radiotherapy in Adult Patients With Diffuse Midline Glioma / Diffuse Intrinsic Pontine Glioma · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04943848Phase 1 · recruiting rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05762419Phase 1 · recruiting FUS Etoposide for DMG · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04541082Phase 1 · recruiting Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05259605recruiting Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03101813recruiting International Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and Repository · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04804709Phase 1 · terminated Non-Invasive Focused Ultrasound (FUS) With Oral Panobinostat in Children With Progressive Diffuse Midline Glioma (DMG) · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02960230Phase 1/Phase 2 · completed H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05500508Phase 1/Phase 2 · terminated Oral AMXT 1501 Dicaprate in Combination With IV DFMO · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04771897Phase 1 · terminated A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG) · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05518838no longer available Expanded Access to OKN-007 for Patients With Diffuse Midline Glioma, H3 K27-altered · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06305910Phase 1 · recruiting CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01922076Phase 1 · completed Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06093165NA · not yet recruiting RE-irradiation of Diffuse MIdline Glioma paTients · condition mapped ONTOLOGY_EXACT · 28 trials mapped (20 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |